Lipid-regulating and antiatherosclerotic therapy: current options and future approaches.
Increased understanding of the mechanisms of cholesterol-lowering therapy and other lipid risk factors has suggested new potential strategies for preventing and treating coronary heart disease (CHD). Although these new strategies hold promise, our first, best strategy for reducing the toll of CHD is to use current guidelines for treating dyslipidemia and other risk factors.
Gotto
A M
AM
Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
D000328:Adult; D003327:Coronary Disease / Q000503:physiopathology / Q000517:prevention & control*; D005260:Female; D015316:Genetic Therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D000960:Hypolipidemic Agents